Search results
The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 21, 2023 – Zacks.com announces the list of stocks...
Novartis sees brighter sales future as R&D revamp continues
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Novartis expects sales to grow faster than anticipated over the next five years as...
Novartis deepens ties with Voyager via $100M gene therapy deal
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Swiss pharmaceutical company Novartis has formed a new collaboration with partner...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
Novartis bet on kidney disease drug yields positive study data
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: An experimental kidney disease drug Novartis acquired via a $3 billion deal earlier this...
Could This Medicine Be the Next Winner for Novartis?
Motley Fool· 9 months agoEarlier this month, the Switzerland-based pharmaceutical Novartis (NYSE: NVS) shared encouraging news from two phase 3 clinical trials of its drug...
Novartis gets FDA approval of closely watched rare disease drug
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: The Food and Drug Administration has approved a new Novartis drug for adults with a rare...
Novartis leans toward spinoff of generic drugs unit - Bloomberg News
Reuters via Yahoo News· 2 years agoA challenging macro environment for leveraged buyouts has made the sale route difficult and Novartis...
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
Motley Fool· 2 years agoOn Sept. 19, Novartis (NYSE: NVS) shared positive news with investors regarding the clinical trial...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 3 weeks agoNovartis blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that...